Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer Torhild VeenArezo KananiKjetil Søreide Review Open access 01 August 2023 Pages: 3135 - 3147
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens Anup Y. ParikhRobert MasiJames C. Yang Research Open access 27 June 2023 Pages: 3149 - 3162
Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics Jiali ChengYuyan ZhaoXiaojian Zhu Research 29 June 2023 Pages: 3163 - 3174
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma Jun TakeiYuko KamataYasuharu Akasaki Research Open access 29 June 2023 Pages: 3175 - 3189
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer Peiwei YangFan YuJuan Zhang Research 07 July 2023 Pages: 3191 - 3202
DLGAP5 promotes gallbladder cancer migration and tumor-associated macrophage M2 polarization by activating cAMP Jie HuangMengyao ZhengDaguang Tian Research 08 July 2023 Pages: 3203 - 3216
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors Fabrizio NelliDiana GiannarelliEnzo Maria Ruggeri Research 10 July 2023 Pages: 3217 - 3228
SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function Yixian GuoShouyu KeHong Lu Research 11 July 2023 Pages: 3229 - 3242
Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2 Zhaojun DuanZhen LiYunping Luo Research 12 July 2023 Pages: 3243 - 3257
Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing Liling HuangNing LouYuankai Shi Research 17 July 2023 Pages: 3259 - 3277
Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma Paola LassoLaura RojasSusana Fiorentino Research Open access 18 July 2023 Pages: 3279 - 3292
Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy Siqi XiongWenqiang ZhuDaya Luo Research 18 July 2023 Pages: 3293 - 3307
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells Marion GrardMohamed IdjellidaineJean-François Fonteneau Research 19 July 2023 Pages: 3309 - 3322
Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia P. K. J. D. de JongeP. M. M. van HautenH. Dolstra Research Open access 21 July 2023 Pages: 3323 - 3335
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events Anna JokimäkiHenna HietalaOuti Kuittinen Research Open access 24 July 2023 Pages: 3337 - 3347
Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment Maria del Mar MaldonadoJeffrey SchlomDuane H. Hamilton Research Open access 28 July 2023 Pages: 3349 - 3362
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps Luca ModestinoLeonardo CristinzianoMaria Rosaria Galdiero Research Open access 31 July 2023 Pages: 3363 - 3376
Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection Julien BalzeauAnindita RavindranSatoko Matsueda Brief Report 19 July 2023 Pages: 3377 - 3385
Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI Rasheed ZakariaMichael D. JenkinsonPhilip S. Rudland Brief Report Open access 21 July 2023 Pages: 3387 - 3393
Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1 Wenjie LiWei Wang Brief Report 27 July 2023 Pages: 3395 - 3399
Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer Jiannan ChenJianhua HuZhigang Guo Correction 14 August 2023 Pages: 3401 - 3403
